Close

Merck (MRK) to Discontinue Development of Odanacatib for Osteoporosis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. BSX


Go back to Merck (MRK) to Discontinue Development of Odanacatib for Osteoporosis
Merck & Co. (NYSE: MRK) Delayed: 130.72 +3.72 (2.93%)
Previous Close $127.00    52 Week High $65.46 
Open $129.69    52 Week Low $47.97 
Day High $132.80    P/E 88.93 
Day Low $128.76    EPS $1.47 
Volume 12,755,151